Skip to main content
logo
Nu-Med Plus, Inc. (NUMD)
OTCMKTS · Delayed Price · Currency is USD
0.0243
+0.0091 (59.87%)
Aug 20, 2026, 3:44 PM EST

Nu-Med Plus Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-0.02-0.06-0.07-0.13-0.13-0.83
Depreciation & Amortization
----0.010.02
Stock-Based Compensation
---0.040.040.2
Other Operating Activities
-----0.05-0.01
Change in Accounts Payable
-0.040.010.030-0.010.03
Change in Other Net Operating Assets
0.0100.030.020.110.38
Operating Cash Flow
-0.05-0.05-0-0.07-0.04-0.21
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-0.05--0.1-
Total Debt Issued
0.050.05--0.1-
Net Debt Issued (Repaid)
0.050.05--0.1-
Issuance of Common Stock
-----0.03
Financing Cash Flow
0.060.05--0.10.03

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
0-0-0-0.070.06-0.18

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-0.05-0.05-0-0.07-0.04-0.21
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.00-0.00--0.00--0.00
Levered Free Cash Flow
-0.14-0.090.02-0.02-0.180.12
Unlevered Free Cash Flow
-0.13-0.090.02-0.02-0.180.12

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.030.010.060.020.10.41